Emed.Com Technologies Peer Comparison

BSE: 524588

₹2.35

₹0.00 (0.00%)

As on 16-Nov-2018IST

Market cap

₹1 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Edit

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Market cap (₹ Cr)	1	2,746	269	241	68
Revenue (₹ Cr)	--	2,901	138	85	45
Net Profit (₹ Cr)	-0.02	16.16	-9.39	12.82	-16.64
Net Margin (%)	--	0.55	-6.66	6.38	-36.43
RoE (%)	-0.52	0.29	-9.20	20.84	--
Price to Earnings	--	169.93	--	18.78	--
Price-To-Book	0.20	0.41	2.85	7.51	--

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Operating Revenue	0.02	6.81	166.27	1,030.13	128.03
Total Income	0.02	7.13	168.62	1,050.88	129.42
Total Expenditure	0.05	5.13	137.62	866.35	132.06
EBITDA	-0.03	1.68	28.65	163.78	-4.03
Depreciation	--	--	10.87	24.79	0.65
EBIT	-0.03	1.68	17.78	138.99	-4.67
Interest	0.00	0.99	25.57	14.79	5.68
Other Income	--	0.32	2.35	20.75	1.39
Exceptional Items	--	--	1.78	--	--
Profit before Tax	-0.03	1.01	-3.66	144.95	-8.96
Provision for Tax	--	0.12	1.06	20.08	-2.75
Profit after Tax	-0.03	0.89	-4.72	124.87	-6.21

Liabilities (₹ Cr)

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Shareholder's Funds	4.02	0.33	43.06	631.29	35.11
Minority Interest	--	--	3.51	40.21	--
Non-Current Liabilities	0.42	8.98	36.95	99.14	0.94
Current Liabilities	0.56	2.80	195.24	443.02	29.87
Total Liabilities	5.01	12.11	278.76	1,213.66	68.38

Assets (₹ Cr)

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Non-Current Assets	4.59	0.00	177.08	587.39	6.14
Current Assets	0.41	12.11	101.69	626.27	59.77
Total Assets	5.01	12.11	278.76	1,213.66	68.38
Total Debt*	0.00	8.98	135.52	336.39	9.42
Net Current Assets	-0.15	9.31	-93.55	183.25	29.90
Contingent Liabilities	--	--	70.58	24.92	4.35

Cashflow (₹ Cr)

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Cash From Operating Activities	-0.03	2.57	26.54	148.13	-9.35
Cash Flow from Investing Activities	-0.01	0.28	28.99	-257.43	1.36
Cash from Financing Activities	-1.44	-2.28	-59.72	113.83	-2.12
Net Cash Inflow / Outflow	-0.03	0.57	-4.20	4.53	-10.12

Ratios

Profitability Ratios

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
ROCE (%)	-0.81	21.05	11.73	18.78	-8.52
ROE (%)	-0.82	0.00	-13.05	21.61	-16.25
ROA (%)	-0.66	7.29	-1.55	11.69	-8.50
EBIT Margin (%)	-162.73	29.37	18.65	17.91	-2.06
Net Margin (%)	-164.84	12.48	-2.80	11.88	-4.80
Cash Profit Margin (%)	-164.84	13.07	3.57	14.53	-4.34

Growth Ratios

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Revenue Growth (%)	-97.81	--	39.89	41.03	-12.44
EBIT Growth (%)	-1,601.98	349.88	123.03	55.87	-163.71
Net Profit Growth (%)	-1,511.04	279.23	10.94	56.22	-501.65
EPS Growth (%)	-1,523.33	279.23	64.91	71.15	-501.66
Book Value Growth (%)	-0.81	158.49	-19.15	20.37	-15.03

Valuation Ratios

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Price / Earnings	0.00	0.00	0.00	14.28	0.00
Price / Book Value	0.76	0.00	4.22	2.71	2.27
Dividend Yield (%)	0.00	--	0.00	0.70	0.00
EV/EBITDA	-93.41	4.22	8.60	10.39	-26.16
Market Cap (₹ Cr)	3.05	0.00	136.60	1,708.91	79.67

Solvency Ratios

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Debt to Equity	0.00	27.21	4.05	0.53	0.27
Short term debt to equity ratio	--	--	1.39	0.40	0.27
Current Ratio	0.73	4.33	0.52	1.41	2.00
Quick Ratio	0.01	4.33	0.43	1.37	1.25
Interest Coverage	-77.22	2.02	0.86	10.80	-0.58

Operating Efficiency Ratios

	Emed.Com Technologies	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Debtors to sales (%)	--	--	34.10	29.26	10.21
Asset Turnover	0.00	0.56	0.57	0.96	1.75
Receivable days	0.00	0.00	132.10	96.01	38.16
Inventory Days	7,606.88	0.00	37.15	7.89	68.59
Payable days	0.00	--	158.77	42.90	51.66
Cash Conversion Cycle	7,606.88	--	10.48	60.99	55.09

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly